NCT02226653View on ClinicalTrials.gov

A Study of Evacetrapib in Healthy Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Evacetrapib

Administered orally

Trial Locations (1)

812-0025

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fukuoka

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02226653 - A Study of Evacetrapib in Healthy Japanese Participants | Biotech Hunter | Biotech Hunter